Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice. [electronic resource]
Producer: 20081020Description: 605-20 p. digitalISSN:- 0344-5704
- Adenoma -- drug therapy
- Animals
- Antineoplastic Agents -- metabolism
- Body Weight -- drug effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Female
- Injections, Intraperitoneal
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred Strains
- Mutation
- Protein Kinase Inhibitors -- metabolism
- Proto-Oncogene Proteins p21(ras) -- genetics
- Quinazolines -- metabolism
- Sex Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.